Gastroenterology Fellowship

Research and Scholarship Expectations

All fellows are expected to actively engage in scholarly activities. These activities can be in basic research, clinical research, health outcomes research, and/or educational research. Essential to success is providing the tools necessary to foster the fellows’ intellectual development as investigators. These tools are provided through participation in VCUHS graduate medical education research series, which is conducted at the start of the academic year and is mandatory for all second year fellows. Fellows receive three research months over the period of their training. Fellows with a strong interest in research can get additional time.

As a sign of our commitment to the scholarly efforts of the fellows, the Department of Internal Medicine has designated funding which is set aside specifically to offset the travel cost for fellows who are presenting their work at regional, national, and international scientific and academic meetings. The division is similarly committed to assisting with costs associated with presenting and publishing scholarly efforts. The commitment to our fellows is evident by the fact that our department chair, Dr. John Nestler, an NIH-funded investigator himself, personally meets with all fellows in advance of presenting at national and international meetings to offer additional mentorship and guidance. At VCU, we honor your education and professional growth as our greatest achievement and are proud to send our residents and fellows as our ambassadors.

Fellows’ publications (2014-15)


Chhatrala, Ravi
Gastroenterology, PGY 5

Abstracts and Presentations
  1. Chhatrala R, Siddiqui MB, Stravitz R, Driscoll C, Sanyal A, Sargeant C, Riyaz F, Luketic V, Sterling R, Matherly S, Puri P, Fisher M. Pro-Atherogenic Lipoproteins and Metabolic Biomarkers Drive Derum Cardiovascular Risk in Liver Transplant Recipients. Poster Presentation, American Association for the Study of Liver Disease Annual Meeting. November 2014, Boston MA.

  2. Chhatrala R, Siddiqui MB, Stravitz R, Driscoll C, Sanyal A, Sargeant C, Luketic V, Sharma A, Sterling R, Matherly S, Puri P. Evolution of the Serum Atherogenic Risk in Liver Transplant Recipients; Role of Lipoproteins, Metabolic and Inflammatory Markers. Poster Presntation, ACG Annual Scientific Meeting. October 2014, Philadelphia PA.
Publications
  1. Chhatrala R, Siddiqui MB, Stravitz R, Driscoll C, Sanyal A, Sargeant C, Luketic V, Sharma A, Sterling R, Matherly S, Puri P. Evolution of the Serum Atherogenic Risk in Liver Transplant Recipients; Role of Lipoproteins, Metabolic and Inflammatory Markers. Liver Transplant J. 5(21);2015;623-30.

Dharel, Narayan
Gastroenterology, PGY 6

Publications
  1. Dharel N, Sterling, RK. Treatment of Hepatitis C, Then, Now and Tomorrow. Evid Based Med. 2015 Feb;20(1):23.

  2. Sterling RK, Dharel N. The Hot HCV Question: Treat Everyone Now or Only Those with Advanced Fibrosis? American Gastroenterology Association Perspectives. February 2015.

  3. Dharel N, Sterling RK. Hepatitis B Virus-HIV Coinfection: Forgotten but Not Gone. Gastroenterology & Hepatology. 10(12);2014;781-88

  4. Acharya C, Dharel N, Sterling RK. Chronic Liver Disease in the Human Immunodeficiency Virus Patient. Clin Liver Dis. 19 (1);2015;1-22.

  5. Dharel N, Fuchs M. Non-alcoholic Fatty Liver Disease. Review. Scientific American Gastroenterology. 2015. (In Press)

  6. Dharel N, Kapoor A, Sanyal AJ. Endoscopic Diagnosis and Management of Variceal Upper Gastrointestinal Bleeding. Gastrointestinal Endoscopy Clinics of North America. 2015. (In Press)

  7. Dharel N, Bajaj JS. Definition and Nomenclature of Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology. 5(1);2015;S37-41.

  8. Dharel N, Bajaj JS. Antibiotic Prophylaxis in Acute Liver Failure: Friend or Foe?. Clin Gastroentrol Hepatol J. 12(11);2014 Nov;1950-2.

Kohli, Divyanshoo
Gastroenterology, PGY 4

Abstracts and Presentations
  1. Kohli D. Endoscopic Management of Esophageal Foreign Bodies. Poster Presntation, ACG Annual Scientific Meeting. October 2014, Philadelphia PA.

Mangray, Sasha
Gastroenterology, PGY 6

Publications
  1. Mangray S, Puri P. Screening for Zinc Deficiency in Cirrhosis-When Should We Start?. Digestive Diseases and Sciences J. 2015. (Submitted)

Nabi, Eiman
Gastroenterology, PGY 4

Publications
  1. Nabi E, Thacker LR, Wade JB, Sterling R, Stravitz R, Fuchs M, Heuman D, Bouneva I, Sanyal A, Siddiqui M, Luketic V, White M, Monteith P, Noble N, Unser A, Bajaj J. Diagnosis of Covert Hepatic Encephalophy without Specialized Tests. Clin Gastroenterol Hepatol J. 2014.

Pacana II, Tommy Y
Gastroenterology, PGY 6

Publications
  1. Pacana T, Sanyal A. Recent Advances in Understanding/Management of Non-Alcoholic Steatohepatitis. F1000Prime Rep. 3(7);2015;28.

  2. MinH, Mirshahi F, Verianelli A, Pacana T, Patel V, Park CG, Choi A, Lee J, Park CB, Ren S, Sanyal A. Activitation of the GP130-STAT3 Axis and It’s Potential Implications in Nonalcoholic Fatty Liver Disease. Am J Physiol Gastrointest Liver Physiol. 308(9);2015;G794-803.

Book Chapters
  1. Pacana T, Sanyal A. Role of Antioxidants in the Nonalcoholic Fatty Liver Disease Spectrum. In: Liver Metabolism and Fatty Liver Disease. CRC Press. 2015;231-246.

Patel, Vaishali
Gastroenterology, PGY 6

Abstracts and Presentations
  1. Patel V, Almenara J, Mirshahi F, Sanyal A. Macrophage Phenotypes in Human NAFLD. Poster Presentation, Digestive Disease Week. May 2015, Washington DC.
Publications
  1. Min H, Mirshahi F, Verdianelli A, Pacana T, Patel V, Park C, Choi A, Lee J, Park CB, Ren S, Sanyal A. Activation of the GP130-STAT3 Axis and It’s Potential Implications in Nonalcoholic Fatty Liver Disease. Am J Physiol Gastrointest Liver Physiol. 308(9);2015;G794-803.

Rahimi Naini, Sohrab
Gastroenterology, PGY 6

Publications
  1. Rahimi Naini S, Fuchs M. Non-Alcoholic Fatty Liver Disease in Patients with Diabetes Mellitus. Expert Review Informa Healthcare. 9(5);2014;503-14.

Vincent, Robert
Gastroenterology, PGY 6

Abstracts and Presentations
  1. Vincent R, Cazanave S, Hae KM, Mirshahi F, Kumar DP, Ashgharpour A, Daitya K, Murthy K, Liang J. Hepatitis C Promotes Diabetes by Increasing hpatic Insulin Resistance and Pancreatic Beta Cell Failure via Suppression of Betatrophin a Novel Islet Cell Growth Factor. Poster Presentation, American Association for the Study of Liver Disease Annual Meeting. November 2014, Boston MA.
Publications
  1. Vincent R, Sanyal A. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Curr Pathobiol Rep. 2014